alert icon Coronavirus

Think you may have COVID-19?
Register for a drive-thru testing appointment

Need a vaccine or booster?
Schedule today

Coming to a Cleveland Clinic location?
Nonessential surgeries postponed in Ohio through Jan. 30, 2022
Visitation and mask requirements

James Young, MD

James Young, MD
  • Watch Video
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Department Executive Board Office
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English
Surgeon No
Locations Specialties & Treatments

Treatment & Services

  • Biventricular Pacemaker
  • cardiac transplant
  • Cardiac Transplantation
  • Cardiology
  • Cardiovascular Medicine
  • Cardiovascular Medicine Department
  • Endomyocardial Biopsy
  • George M & Linda H Kaufman Center for Heart Failure
  • Heart Biopsy
  • Heart Failure Management
  • Heart Failure Section
  • Heart Transplantation
  • Mechanical Assist Devices
  • Pre-Transplant Evaluation
  • Transplant
  • Ventricular Assist Device
View all 16 Treatment & Services +

Specialty in Diseases & Conditions

  • Amyloid Sarcoid Heart Disease
  • Amyloidosis
  • Cardiac Amyloid Imaging
  • Cardiac transplant
  • Cardiomyopathy
  • Cardiomyopathy Secondary to Chemotherapy
  • Cardiomyopathy Valvular
  • Congestive Heart Failure (CHF)
  • Dilated Cardiomyopathy
  • Ejection Fraction
  • Ejection Fraction - Abnormal
  • Enlarged Heart
  • Familial Amyloidosis
  • Familial Cardiomyopathy
  • Heart Failure
  • Heart Failure In Women
  • Hypertrophic Cardiomyopathy
  • Infiltrative Cardiomyopathy
  • Ischemic Cardiomyopathy
  • Mechanical Circulatory Support
  • Myocarditis
  • Nonischemic Cardiomyopathy
  • Restrictive Cardiomyopathy
  • Sarcoid Heart Disease
  • Shortness Of Breath
View all 25 Specialties +


Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans

About James Young, MD

Dr. Young has been appointed the Cleveland Clinic’s Chief Academic Officer.  He will oversee Research and Education and emphasize the importance of these areas to the mission of our enterprise. He is a Professor of Medicine and served as Executive Dean of the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University from 2009-2018. He also served as Chairman of the Endocrinology and Metabolism Institute from 2008-2018.  He is a Physician Director of the Philanthropy Institute and co-founder of the Kaufman Center for Heart Failure in the Heart, Vascular & Thoracic Institute.  He holds the George and Linda Kaufman Chair. As Study Chairman over the past decade of the NIH, FDA, and CMS Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS), Dr. Young maintains an active professional role in the fields of heart failure, heart transplant, and MCSD development. He has a joint appointment to the Clinic’s Multi-organ Transplant Center and the Heart, Vascular & Thoracic Institute.  Dr. Young is certified as Diplomat of the American Board of Internal Medicine and the subspecialties of Cardiovascular Disease and Advanced Heart Failure and Transplant Cardiology.  He holds medical licensure from the states of California, Illinois, Ohio, and Texas.

In addition to office visits, Dr. Young also offers scheduled follow up virtual visits to select patients, through the Cleveland Clinic Express Care ® Online app. This platform allows patients to see their physician live, using their smartphone, tablet or computer.

Dr. Young spent his early years in the San Francisco Bay area and then attended the University of Kansas, where he received his Bachelor of Arts degree with Honors in Biology and was a resident of Stephenson Scholarship Hall. He matriculated to Baylor College of Medicine in Houston, Texas, where he was awarded his Medical Doctor degree cum laude in 1974 and was elected to the Alpha Omega Alpha medical honor society. Dr. Young remained in Houston at Baylor Affiliated Hospitals where he completed his clinical training, subsequently joined the faculty and was named Professor of Medicine with tenure in 1992. During this time, he was the Clinical Coordinator and Scientific Director for Dr. Michael E. DeBakey’s Multi-organ Transplant Center at The Methodist Hospital and Baylor College of Medicine.

Dr. Young relocated to Cleveland and the Cleveland Clinic in 1995 where he was named Head of the Section of Heart Failure and Cardiac Transplant Medicine in the Department of Cardiovascular Disease. In 1998 Dr. Young and his surgical colleague Patrick McCarthy, MD, created the Kaufman Center for Heart Failure at Cleveland Clinic.

Dr. Young’s research activities began during his residency and fellowship training while he was a Lipid Research Clinic (LRC) physician. He subsequently focused his efforts on heart failure, mechanical circulatory support, and cardiac transplant therapeutics, including early experiences with dopamine receptor agonists, angiotensin-converting enzyme inhibitors, beta blockers, calcium channel blockers, angiotensin receptor blockers, many new immunosuppressants and a variety of parenteral inotropes and vasodilators. He has collaborated extensively with his basic science research associates, focusing on translational research related to the molecular biology of cardiac remodeling, allograft arteriopathy and transplanted heart rejection.

Dr. Young has participated in more than 150 clinical trials as an investigator and served as the U.S. Principal or Co-Principal Investigator for the HOPE, RESOLVED, SPICE, VMAC, MIRACLE-ICD, RED-HF, ACCLAIM, ONTARGET, TRENSCEND and CHARM multi-center clinical trials. He has published more than 550 manuscripts and several textbooks. Professionally, Dr. Young gains the greatest satisfaction from his contributions to the development and administration of donor organ procurement programs, his efforts to secure recognition for the emerging cardiology subspecialty of ‘heart failure and cardiac transplant medicine, and his collaborations with basic and clinical scientists.

Education & Professional Highlights

Education & Professional Highlights


Education & Fellowships

Fellowship - Baylor College of Medicine Affiliated Hospitals
Houston, TX USA

Residency - Baylor College of Medicine Affiliated Hospitals
Internal Medicine
Houston, TX USA

Internship - Baylor College of Medicine Affiliated Hospitals
Internal Medicine
Houston, TX USA

Medical Education - Baylor College of Medicine
Houston, TX USA

Undergraduate - University of Kansas
Lawrence, KS USA

Professional Highlights

  • International Society of Heart and Lung Transplantation, Board Member and Past President
  • Heart Failure Society of America, Board Member
  • American Society of Transplantation, Board Member


  • Internal Medicine
  • Internal Medicine - Cardiovascular Disease
  • Internal Medicine - Advanced Heart Failure and Transplant Cardiology

Specialty Interests

Cardiomyopathy, cardiac tumors, heart failure, heart transplantation, ventricular assist device

Awards & Honors

  • Fellow, American College of Cardiology
  • Fellow, American College of Chest Physicians
  • Fellow, American College of Physicians
  • Fellow, American Heart Association
  • Fellow, European Society of Cardiology
  • Gold Medal for Meritorious Service to Yugoslavian Cardiology Society
  • Naifeh and Smita Guide: The Best Doctors in America
  • Castle Connolly Guide: American Top Doctors


  • American College of Cardiology
  • American Heart Association
  • European Society of Cardiology
  • Heart Failure Society of America
  • International Society for Heart and Lung Transplantation
Research & Publications

Research & Publications

See publications for James Young, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/4/2021, Dr. Young has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Young receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Biogen Idec, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Related Videos Featuring James Young, MD

Related Videos Featuring James Young, MD

Back to Top